Anavar vs Winstrol: complete comparison (orals, cutting, profile)
| Critère | anavar | winstrol |
|---|---|---|
| Anabolic/androgenic ratio | 322:24 | 320:30 |
| Half-life | ~9 h | ~9 h (oral) / 24 h (injectable) |
| Hepatotoxicity | Moderate (17α-alkylated) | High (17α-alkylated) |
| Aromatization | No | No |
| HPG axis suppression | Moderate | Moderate to strong |
| Male dose | 40-80 mg/d | 40-60 mg/d |
| Female dose | 5-10 mg/d | 5-10 mg/d |
| Joint effect | Neutral | Dryness, pain |
Quand choisir anavar
Anavar (oxandrolone) is the mildest oral in the AAS landscape, and the only one supported by quality human clinical trials: Strawford 1999 and Wolf 2006 (RCTs in HIV-wasting and major burn patients) demonstrate clear anabolic efficacy without major toxicity at therapeutic doses (10-20 mg/day). Choose it for deep cuts (anti-catabolic effect preserving lean mass in caloric deficit), for women (5-10 mg/d is the near-non-virilization window), or as a 'light oral kickstart' of an injectable cycle. Very weak androgenic profile (ratio 322:24 on rat — Kicman 2008): little risk of acne or hair loss compared to other orals. Its 'women's steroid' reputation is deserved: its low affinity for the cutaneous androgen receptor and its mild kinetics make it markedly more tolerable. Limitations: very real hepatotoxicity despite the 'anavar safe' myth (Niedfeldt 2018: oxandrolone classified as 17α-alkylated with moderate hepatic risk), and clearly degraded lipid profile even on short cycles (HDL crash). Limit to 6-8 weeks, ALT/AST and lipid monitoring every 4 weeks.
Quand choisir winstrol
Winstrol (stanozolol) is the classic oral for competitive cuts: it strongly displaces testosterone from SHBG (the most marked mechanism of all AAS, according to Saartok 1984), increasing available free testosterone — hence the immediate 'hardness' visual effect. No aromatization (Soma 2007: stanozolol DHT-derived non-aromatizable), drier skin, increased vascularity, sensation of 'muscular fullness' without retention. Choose it for finishing a cut, pre-competition, or as additive in the last 4-6 weeks of a cutting cycle. Major drawbacks (Kicman 2008, Niedfeldt 2018): hepatotoxicity among the highest of 17α-alkylated orals, joint dryness potentially causing tendon pain or partial ruptures on heavy training, very degraded lipid profile (HDL collapse). Also available in injectable form (Winstrol Depot): no less hepatotoxic because same 17α-alkylated molecule, but more stable kinetics. Typical dose 40-60 mg/d oral × 4-6 weeks. Not for users already with a defavorable lipid panel at baseline.
Combinaison ?
No simultaneous anavar + winstrol combination: stacking two 17α-alkylated orals doubles hepatic load without significant anabolic benefit. Prudence rule: 'one oral at a time' in a given cycle. If you want both benefits, structure in sequence: anavar 40 mg/d as kickstart of a cutting cycle for 6 weeks, then winstrol 50 mg/d for the last 4 weeks pre-contest, with a 2-week oral-free window between blocks to allow hepatic recovery. Always on an injectable testosterone base (200-300 mg/week) because both suppress the HPG axis without ensuring complete androgenic function — otherwise erectile dysfunction and libido drop guaranteed from week 3. ALT/AST and lipid monitoring at W0, W4, W8 of the global cycle, with immediate stop if transaminases > 3× normal. Hepatoprotectors (NAC 600 mg × 2, TUDCA 500 mg, milk thistle) recommended but do not dispense with biological monitoring. Pre-existing matters: borderline liver or lipid profile at baseline contraindicates this sequential combination. Sample sequential timeline (16-week cycle with sequence): W0 baseline ALT/AST/CMP/lipids, W2 first hepatic check (anavar block), W4 ALT/AST + lipids, W6 end of anavar block, W7-W8 2-week oral break with hepatic recheck, W9 winstrol start, W11 ALT/AST + lipids (critical, two compounds cumulated), W13 final pre-contest panel, W14 last winstrol then 2-week wash-out, W16 PCT start. Joint care during winstrol block: glucosamine 1500 mg + chondroitin 1200 mg + omega-3 3 g daily, reduce eccentric volume by 20%, avoid 1-rep max attempts. Many practitioners simply skip the sequential approach and use only one oral per testo cycle to minimize hepatic load. Independent lab testing for both orals recommended — anavar mislabeling rate as high as 40% per some analyses.
FAQ
- Is anavar really hepatic-free?
- No, that is a myth. Oxandrolone is 17α-alkylated, and the chemical modification that allows it to resist first-pass hepatic metabolism is the same that makes it hepatotoxic. Strawford 1999 and Wolf 2006 document ALT and AST elevations in 20-30% of patients under 20 mg/d × 12 weeks. The difference with winstrol or dianabol: lower amplitude of elevation and faster resolution on cessation. Limit to 6-8 weeks, biological monitoring non-negotiable.
- Anavar or winstrol for women?
- Anavar almost exclusively. Its low affinity for the cutaneous androgen receptor and mild kinetics allow use at 5-10 mg/d over 4-6 weeks with minimal virilization risk (voice, hirsutism, clitoris). Winstrol, while weakly androgenic on ratio, has more aggressive bioavailability and causes virilization in ~30% of women at 10 mg/d. For those aiming at hardness and performance without mass, oxandrolone remains the standard.
- Why does winstrol cause joint pain?
- Two superimposed mechanisms (Kicman 2008): (1) marked estrogen suppression (via SHBG displacement and relative competition) reduces synovial lubrication that partly depends on estradiol; (2) generalized cutaneous dryness extends to peri-articular connective tissues. Result: stiffness of elbows, knees, shoulders under heavy loads. Mitigate with: monitored estradiol not too low, hydration +1L/day, glucosamine-chondroitin, moderate loads during winstrol season. Several tendon ruptures documented in winstrol-only users.
- Which oral for a first mass cycle?
- Neither. Anavar and winstrol are cutting/definition orals, not bulking. For a first mass cycle, choose dianabol (kickstart) or turinabol (slightly less effective but milder profile), always on injectable testosterone base. Anavar can possibly serve as kickstart in a cut, but its raw anabolic potency remains inferior to mass orals.
- How much realistic gain with anavar or winstrol alone?
- In solo cycle (inadvisable because suppression without androgen substitution): anavar 60 mg/d × 6 weeks = +2 to +3 kg lean mass, mainly through anti-catabolic effect in deficit. Winstrol 50 mg/d × 6 weeks = +1 to +2 kg with more marked dry visual effect than raw mass. All serious users pair them with a testosterone base (200-400 mg/week) which multiplies efficacy by 2-3 and preserves the androgenic axis. The oral solo cycle is a bad risk/benefit ratio.
- Do you need PCT after anavar or winstrol alone?
- Yes, even in oral solo cycle. Both molecules suppress the HPG axis moderately but really (Rahnema 2014). Minimal protocol: nolvadex 20 mg/d × 4 weeks, started 3-4 days after the last oral dose (short half-life ~9 h). T total and LH panel at W8 post-cycle to confirm recovery. PCT is longer and more demanding after a testo-based injectable cycle.
- Why limit to 6-8 weeks?
- The hepatotoxic profile of 17α-alkylated drugs is cumulative: transaminases rise linearly with exposure duration (Niedfeldt 2018), and the risk of cholestasis and hepatic peliosis climbs beyond 8 weeks. The empirical rule '6 weeks then minimum 6-week hepatic break' applies to both anavar and winstrol. An ALT/AST elevation > 3× baseline requires immediate stop with weekly monitoring until return to normal.
- Is injectable winstrol less hepatotoxic than oral?
- Marginally, but not as much as claimed. The same 17α-alkylated molecule passes through the liver in first-pass metabolism whether absorbed orally or injected — the chemical modification alone determines hepatic load, not the entry route. The more stable kinetics of injectable slightly reduce peaks of hepatic exposure but does not change the nature of metabolism. Always prefer injection to avoid the painful gastric dissolution phase, but do not falsely reassure on toxicity.